Arvinas (NASDAQ:ARVN) initiated with Outperform rating and $38 (61% upside) price target at Wedbush.
Minerva Neurosciences (NASDAQ:NERV) initiated with Buy rating and $17 (107% upside) price target at Chardan.
Strongbridge Biopharma (NASDAQ:SBBP) initiated with Outperform rating and $8 (211% upside) at Evercore ISI.
UniQure (NASDAQ:QURE) initiated with Outperform rating and $73 (71% upside) price target at Bernstein.
Momenta Pharmaceuticals (NASDAQ:MNTA) initiated with Buy rating and $24 (83% upside) price target at H.C. Wainwright.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.